chrX-77600552-T-G

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_000489.6(ATRX):​c.5579A>C​(p.Asn1860Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000283 in 1,097,128 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 11 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N1860S) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 0.000028 ( 0 hom. 11 hem. )

Consequence

ATRX
NM_000489.6 missense

Scores

14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.03

Publications

22 publications found
Variant links:
Genes affected
ATRX (HGNC:886): (ATRX chromatin remodeler) The protein encoded by this gene contains an ATPase/helicase domain, and thus it belongs to the SWI/SNF family of chromatin remodeling proteins. This protein is found to undergo cell cycle-dependent phosphorylation, which regulates its nuclear matrix and chromatin association, and suggests its involvement in the gene regulation at interphase and chromosomal segregation in mitosis. Mutations in this gene are associated with X-linked syndromes exhibiting cognitive disabilities as well as alpha-thalassemia (ATRX) syndrome. These mutations have been shown to cause diverse changes in the pattern of DNA methylation, which may provide a link between chromatin remodeling, DNA methylation, and gene expression in developmental processes. Multiple alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2017]
ATRX Gene-Disease associations (from GenCC):
  • alpha thalassemia-X-linked intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • ATR-X-related syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability-hypotonic facies syndrome, X-linked, 1
    Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.14432925).
BS2
High Hemizygotes in GnomAdExome4 at 11 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000489.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATRX
NM_000489.6
MANE Select
c.5579A>Cp.Asn1860Thr
missense
Exon 23 of 35NP_000480.3
ATRX
NM_138270.5
c.5465A>Cp.Asn1822Thr
missense
Exon 22 of 34NP_612114.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATRX
ENST00000373344.11
TSL:1 MANE Select
c.5579A>Cp.Asn1860Thr
missense
Exon 23 of 35ENSP00000362441.4
ATRX
ENST00000395603.7
TSL:1
c.5465A>Cp.Asn1822Thr
missense
Exon 22 of 34ENSP00000378967.3
ATRX
ENST00000480283.5
TSL:1
n.*5207A>C
non_coding_transcript_exon
Exon 24 of 36ENSP00000480196.1

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD4 exome
AF:
0.0000283
AC:
31
AN:
1097128
Hom.:
0
Cov.:
29
AF XY:
0.0000303
AC XY:
11
AN XY:
362770
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26362
American (AMR)
AF:
0.00
AC:
0
AN:
35184
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19345
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30083
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54131
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40456
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4131
European-Non Finnish (NFE)
AF:
0.0000357
AC:
30
AN:
841397
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46039
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
22
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Alpha thalassemia-X-linked intellectual disability syndrome Uncertain:1
Jul 21, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces asparagine, which is neutral and polar, with threonine, which is neutral and polar, at codon 1860 of the ATRX protein (p.Asn1860Thr). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ATRX-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ATRX protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
17
DANN
Benign
0.88
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.82
T
M_CAP
Benign
0.072
D
MetaRNN
Benign
0.14
T
MetaSVM
Benign
-0.49
T
PhyloP100
1.0
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.81
N
REVEL
Benign
0.19
Sift
Benign
0.21
T
Sift4G
Benign
0.56
T
Vest4
0.065
MutPred
0.61
Gain of phosphorylation at N1860 (P = 0.069)
MVP
0.63
MPC
1.4
ClinPred
0.10
T
GERP RS
3.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.31
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45439799; hg19: chrX-76856021; API